Molecules/LEBRIKIZUMAB

LEBRIKIZUMAB

Molecular Identity

AntibodyApprovedFirst approved 2023

Mechanism of action: Interleukin-13 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

EBGLYSSLEBRIKIZUMABLEBRIKIZUMAB-LBKZMILR-1444AMILR1444APRO-301444PRO301444PRO-301444 RG-3637RO-5490255TNX-650

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to LEBRIKIZUMAB

Loading drug network...